291 related articles for article (PubMed ID: 16143455)
1. Clinical features of gamma-hydroxybutyrate and gamma-butyrolactone toxicity and concomitant drug and alcohol use.
Liechti ME; Kunz I; Greminger P; Speich R; Kupferschmidt H
Drug Alcohol Depend; 2006 Feb; 81(3):323-6. PubMed ID: 16143455
[TBL] [Abstract][Full Text] [Related]
2. Presentations to an urban emergency department in Switzerland due to acute γ-hydroxybutyrate toxicity.
Liakoni E; Walther F; Nickel CH; Liechti ME
Scand J Trauma Resusc Emerg Med; 2016 Aug; 24(1):107. PubMed ID: 27581664
[TBL] [Abstract][Full Text] [Related]
3. Clinical course of gamma-hydroxybutyrate overdose.
Chin RL; Sporer KA; Cullison B; Dyer JE; Wu TD
Ann Emerg Med; 1998 Jun; 31(6):716-22. PubMed ID: 9624311
[TBL] [Abstract][Full Text] [Related]
4. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD).
Wood DM; Warren-Gash C; Ashraf T; Greene SL; Shather Z; Trivedy C; Clarke S; Ramsey J; Holt DW; Dargan PI
QJM; 2008 Jan; 101(1):23-9. PubMed ID: 18203723
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of ethanol coingestion in patients with GHB/GBL intoxication.
Galicia M; Dargan PI; Dines AM; Yates C; Heyerdahl F; Hovda KE; Giraudon I; ; Wood DM; Miró Ò;
Toxicol Lett; 2019 Oct; 314():37-42. PubMed ID: 31301370
[TBL] [Abstract][Full Text] [Related]
6. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B
Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383
[TBL] [Abstract][Full Text] [Related]
7. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies.
McDaniel CH; Miotto KA
J Psychoactive Drugs; 2001; 33(2):143-9. PubMed ID: 11476261
[TBL] [Abstract][Full Text] [Related]
8. Intoxication by gamma hydroxybutyrate and related analogues: Clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse.
Miró Ò; Galicia M; Dargan P; Dines AM; Giraudon I; Heyerdahl F; Hovda KE; Yates C; Wood DM; Liakoni E; Liechti M; Jürgens G; Pedersen CB; O'Connor N; Markey G; Moughty A; Lee C; O'Donohoe P; Sein Anand J; Puiguriguer J; Homar C; Eyer F; Vallersnes OM; Persett PS; Chevillard L; Mégarbane B; Paasma R; Waring WS; Põld K; Rabe C; Kabata PM
Toxicol Lett; 2017 Aug; 277():84-91. PubMed ID: 28579487
[TBL] [Abstract][Full Text] [Related]
9. Abrupt awakening phenomenon associated with gamma-hydroxybutyrate use: a case series.
Van Sassenbroeck DK; De Neve N; De Paepe P; Belpaire FM; Verstraete AG; Calle PA; Buylaert WA
Clin Toxicol (Phila); 2007; 45(5):533-8. PubMed ID: 17503262
[TBL] [Abstract][Full Text] [Related]
10. [Gamma-hydroxybutyrate (GHB) and its lactone (GBL) as psychoactive substances].
Krajewska A; Kwiecień-Obara E; Szponar J; Majewska M; Kołodziej M
Przegl Lek; 2012; 69(8):544-7. PubMed ID: 23243924
[TBL] [Abstract][Full Text] [Related]
11. Physostigmine for gamma-hydroxybutyrate coma: inefficacy, adverse events, and review.
Zvosec DL; Smith SW; Litonjua R; Westfal RE
Clin Toxicol (Phila); 2007; 45(3):261-5. PubMed ID: 17453877
[TBL] [Abstract][Full Text] [Related]
12. Intoxications due to ingestion of gamma-butyrolactone: organ distribution of gamma-hydroxybutyric acid and gamma-butyrolactone.
Lenz D; Rothschild MA; Kröner L
Ther Drug Monit; 2008 Dec; 30(6):755-61. PubMed ID: 18824955
[TBL] [Abstract][Full Text] [Related]
13. Acute toxicity and withdrawal syndromes related to γ-hydroxybutyrate (GHB) and its analogues γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD).
Wood DM; Brailsford AD; Dargan PI
Drug Test Anal; 2011; 3(7-8):417-25. PubMed ID: 21548140
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of equimolar doses of gamma-hydroxybutyrate (GHB), 1,4-butanediol (1,4-BD) and gamma-butyrolactone (GBL) on catalepsy after acute and chronic administration.
Towiwat P; Phattanarudee S; Maher TJ
Food Chem Toxicol; 2013 Jan; 51():337-42. PubMed ID: 23104245
[TBL] [Abstract][Full Text] [Related]
15. [GHB, GBL and butanediol poisonings--a serious problem in Western Sweden].
Knudsen K; Greter J; Verdicchio M; Cederquist T
Lakartidningen; 2005 Nov 7-13; 102(45):3294-6, 3299. PubMed ID: 16342543
[TBL] [Abstract][Full Text] [Related]
16. High mortality rates among GHB abusers in Western Sweden.
Knudsen K; Greter J; Verdicchio M
Clin Toxicol (Phila); 2008 Mar; 46(3):187-92. PubMed ID: 18344100
[TBL] [Abstract][Full Text] [Related]
17. [First report of lethal gamma-hydroxybutyrate (GHB) intoxication after consumption of gamma-butyrolactone (GBL) in Lower Saxony].
Fieguth A; Albrecht K; Weller JP; Kühnle R; Teske J
Arch Kriminol; 2009; 223(1-2):45-51. PubMed ID: 19323150
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of patients with analytically confirmed γ-hydroxybutyric acid/γ-butyrolactone (GHB/GBL)-related emergency department visits in Taiwan.
Weng TI; Chen LY; Chen JY; Chen GY; Mou CW; Chao YL; Fang CC
J Formos Med Assoc; 2021 Oct; 120(10):1914-1920. PubMed ID: 33893011
[TBL] [Abstract][Full Text] [Related]
19. [Acute gamma-butyrolactone poisoning with withdrawal syndrome].
Chwaluk P; Rejmak G
Przegl Lek; 2011; 68(8):537-8. PubMed ID: 22010460
[TBL] [Abstract][Full Text] [Related]
20. Gamma-hydroxybutyrate: a 30 month emergency department review.
Munir VL; Hutton JE; Harney JP; Buykx P; Weiland TJ; Dent AW
Emerg Med Australas; 2008 Dec; 20(6):521-30. PubMed ID: 19125832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
